By Fineline Cube The National Medical Products Administration (NMPA) has granted marketing approval for the “coronary artery interventional surgery control system” and “disposable coronary artery interventional surgery control system attachment,” both developed by Medtronic Inc.’s subsidiary Corindus Inc., based in the US.
Enhancing Surgical Precision and Safety
This approval highlights a significant step forward in the field of robotic-assisted coronary intervention surgery. The system, which includes an operating console and robotic arm with supporting accessories, is designed to be used in a shielded environment. Doctors can control intervention instruments remotely, reducing their exposure to radiation during surgery. This innovative approach not only enhances the safety of medical professionals but also improves the precision of surgical procedures.
Quantitative Vascular Measurement and Lesion Assessment
Moreover, the product’s capabilities extend to quantitative vascular size measurement, which aids doctors in determining the length of lesions with greater accuracy. This feature is particularly valuable in planning and executing coronary interventions, as it allows for more informed decision-making and tailored treatment strategies.-Fineline Info & Tech